Sotio
Europe, Hlavni mesto Praha, Czech Republic, Prague
Description
Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Investor Profile
Sotio has made 1 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series A (100%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Oncology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
